In vitro and in vivo Acute Lymphoblastic Leukemia (ALL) models reveal that MIF is positively regulated by UHRF1 (ICBP90) and negatively regulated by HBP1, both of which drive MIF overexpression in disease progression by binding to the promotor region. The gene discussed is MIF; the disease is acute lymphoblastic leukemia.